CLOS
Compagnie Lombard Odier SCmA’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.3K | Sell |
3,000
-500
| -14% | -$8.38K | ﹤0.01% | 326 |
|
|
2025
Q1 | $53.8K | Buy |
+3,500
| New | +$53.8K | ﹤0.01% | 347 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 726 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 705 |
|
|
2022
Q1 | – | Sell |
-1,000
| Closed | -$8K | – | 678 |
|
|
2021
Q4 | $8K | Buy |
+1,000
| New | +$8K | ﹤0.01% | 627 |
|
|
2021
Q3 | – | Sell |
-2,000
| Closed | -$20K | – | 695 |
|
|
2021
Q2 | $20K | Buy |
2,000
+1,200
| +150% | +$12K | ﹤0.01% | 552 |
|
|
2021
Q1 | $9K | Hold |
800
| – | – | ﹤0.01% | 604 |
|
|
2020
Q4 | $8K | Hold |
800
| – | – | ﹤0.01% | 529 |
|
|
2020
Q3 | $7K | Sell |
800
-2,560
| -76% | -$22.4K | ﹤0.01% | 470 |
|
|
2020
Q2 | $42K | Buy |
3,360
+2,560
| +320% | +$32K | ﹤0.01% | 389 |
|
|
2020
Q1 | $7K | Sell |
800
-9,000
| -92% | -$78.8K | ﹤0.01% | 448 |
|
|
2019
Q4 | $96K | Hold |
9,800
| – | – | ﹤0.01% | 317 |
|
|
2019
Q3 | $68K | Buy |
9,800
+6,000
| +158% | +$41.6K | ﹤0.01% | 335 |
|
|
2019
Q2 | $34K | Sell |
3,800
-50,000
| -93% | -$447K | ﹤0.01% | 385 |
|
|
2019
Q1 | $844K | Hold |
53,800
| – | – | 0.03% | 161 |
|
|
2018
Q4 | $829K | Sell |
53,800
-200,000
| -79% | -$3.08M | 0.03% | 165 |
|
|
2018
Q3 | $5.47M | Buy |
253,800
+1,720
| +0.7% | +$37.1K | 0.19% | 86 |
|
|
2018
Q2 | $6.13M | Hold |
252,080
| – | – | 0.23% | 80 |
|
|
2018
Q1 | $4.31M | Sell |
252,080
-292,080
| -54% | -$4.99M | 0.16% | 101 |
|
|
2017
Q4 | $10.3M | Buy |
544,160
+272,080
| +100% | +$5.16M | 0.19% | 95 |
|
|
2017
Q3 | $4.79M | Buy |
272,080
+18,000
| +7% | +$317K | 0.17% | 111 |
|
|
2017
Q2 | $8.44M | Buy |
254,080
+180,000
| +243% | +$5.98M | 0.29% | 74 |
|
|
2017
Q1 | $2.38M | Buy |
74,080
+19,500
| +36% | +$626K | 0.08% | 159 |
|
|
2016
Q4 | $1.98M | Buy |
54,580
+50,843
| +1,361% | +$1.84M | 0.06% | 190 |
|
|
2016
Q3 | $172K | Sell |
3,737
-3,700
| -50% | -$170K | 0.01% | 489 |
|
|
2016
Q2 | $373K | Buy |
7,437
+2,500
| +51% | +$125K | 0.01% | 388 |
|
|
2016
Q1 | $264K | Sell |
4,937
-6,820
| -58% | -$365K | 0.01% | 442 |
|
|
2015
Q4 | $772K | Sell |
11,757
-3,600
| -23% | -$236K | 0.02% | 264 |
|
|
2015
Q3 | $867K | Buy |
15,357
+4,332
| +39% | +$245K | 0.04% | 217 |
|
|
2015
Q2 | $652K | Buy |
11,025
+75
| +0.7% | +$4.44K | 0.02% | 267 |
|
|
2015
Q1 | $682K | Buy |
10,950
+3,770
| +53% | +$235K | 0.03% | 271 |
|
|
2014
Q4 | $413K | Sell |
7,180
-3,397
| -32% | -$195K | 0.02% | 293 |
|
|
2014
Q3 | $570K | Sell |
10,577
-2,477
| -19% | -$133K | 0.02% | 289 |
|
|
2014
Q2 | $684K | Sell |
13,054
-40,033
| -75% | -$2.1M | 0.03% | 255 |
|
|
2014
Q1 | $2.81M | Sell |
53,087
-30,175
| -36% | -$1.59M | 0.12% | 112 |
|
|
2013
Q4 | $3.34M | Buy |
+83,262
| New | +$3.34M | 0.14% | 99 |
|